Cohbar (OTCMKTS:CWBR) Releases Quarterly Earnings Results

Cohbar (OTCMKTS:CWBR) announced its quarterly earnings results on Wednesday. The company reported ($0.07) earnings per share for the quarter, Bloomberg Earnings reports.

Shares of OTCMKTS CWBR traded up $0.04 during trading hours on Friday, hitting $1.63. 20,579 shares of the stock were exchanged, compared to its average volume of 92,318. The firm’s fifty day simple moving average is $1.60. Cohbar has a 12 month low of $1.30 and a 12 month high of $7.40.

Cohbar Company Profile

CohBar, Inc, a biotechnology company, engages in the research and development of mitochondria based therapeutics (MBTs) to treat various diseases associated with aging and metabolic dysfunction. Its lead MBT drug candidates include CB4209 and CB4211, which are in IND-enabling studies for the treatment of fatty liver disease, non-alcoholic steatohepatitis, obesity, and type 2 diabetes mellitus.

Featured Article: What is the Current Ratio?

Earnings History for Cohbar (OTCMKTS:CWBR)

Receive News & Ratings for Cohbar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cohbar and related companies with MarketBeat.com's FREE daily email newsletter.